William Blair Hires Head of Biopharma Investment Banking, based in New York

NEW YORK--(BUSINESS WIRE)--William Blair announced today the expansion of the firm’s Healthcare team with the addition of Michael Allwin as managing director and head of Biopharma investment banking. Based in New York, Allwin will lead the firm’s global efforts to provide comprehensive advisory services to public and private biopharma companies across all stages of development as well as financial sponsors and venture firms focused on the sector.

“Michael will play a critical role in further expanding our biopharma industry platform, while enhancing our coverage of this fast-paced and complex vertical,” said Steve Tole, managing director and head of Healthcare investment banking at William Blair. “He brings a strong reputation as an advisor who provides sophisticated capital-raising solutions and strategic advice with robust client service to companies and investors that are driving innovations across the biopharma sector.”

Allwin joins from Truist Securities, where he was managing director and head of biopharma investment banking. His nearly 15 years of experience in biopharma also includes investment banking roles at Credit Suisse, RBC Capital Markets, and Deutsche Bank, with extensive experience in deal origination and execution of M&A and equity and equity-linked transactions, IPOs, follow-ons, private placements, debt securities, PIPEs, and venture capital funding. He received his B.A. in political science and economics from Bucknell University.

“William Blair’s global Healthcare investment banking team is world renowned and highly respected, and the firm’s momentum in biopharma shows a deep understanding of the innovations and leaders shaping the sector,” Allwin said. “Leveraging industry-specific technical expertise, William Blair offers clients a full suite of capital-raising and strategic advisory solutions, deep investor relationships, and a steadfast commitment to client service. I’m honored to be a part of William Blair’s Healthcare team and the firm’s global network of professionals.”

Allwin is the latest senior banker to join William Blair this year. Other additions include Robert Engelhardt, Tech Enabled Services director in Frankfurt; Jayant Dey, managing director in the energy sector in New York; Alain Harfouche, managing director focused on chemicals in New York; Matthew Wolfe, who leads the firm’s technology Equity Capital Markets coverage; and Rishi Sethi, FinTech managing director in London. The firm also acquired Inner Circle Sports, adding sports, media, and entertainment to its sector coverage and more than 15 bankers to its investment banking team.

About William Blair Investment Banking

William Blair’s investment banking group enables corporations, financial sponsors, and owner/entrepreneurs around the world to achieve their growth, liquidity, and financing objectives. Drawing on the collective intellectual capital and deep sector expertise of a global team that reaches over 30 cities on four continents, the investment banking group brings a rigorous and innovative approach to corporate board advisory projects, mergers and acquisitions, and equity and debt financing. From April 2021 through March 2026, the team advised on more than $820 billion in completed transaction volume.

About William Blair

William Blair is the premier global partnership with expertise in investment banking, investment management, and private wealth management. We provide advisory services, strategies, and solutions to meet our clients’ evolving needs. As an independent and employee-owned firm, together with our strategic partners, we operate in more than 30 offices worldwide.*

*Includes strategic alliances with Allier Capital, BDA Partners, and Poalim Equity Ltd.